Clinical research
The aim of clinical research in cancerology is to assess the efficacy and tolerance of new innovative therapies.
A range of services for different disciplines
At the Centre Azuréen de Cancérologie, we offer a wide range of clinical trials to patients with various conditions, including prostate cancer, breast cancer, gynaecological cancers, lung cancer and gastrointestinal cancers. Two clinical research coordinators dedicated to this work are based at the Centre to select eligible patients and ensure they receive the best possible care. An advanced practice nurse specialising in clinical research is also on hand to improve the care pathway for patients participating in clinical trials.
We currently offer a wide range of clinical trials. Our commitment to research has been the subject of numerous international presentations and publications.
CAC Clinical Research
Clinical trials are a key pillar of medical progress. They provide access to new techniques for the diagnosis and treatment of cancer, whilst ensuring enhanced monitoring and personalised care.
Committed to excellence in oncology across our region, we contribute every day to the development of therapeutic solutions designed to improve the care of patients today and in the future.
The Centre Azuréen de Cancérologie plays an active role in the ONCO-PACA network, offering its patients innovative treatment protocols that have been evaluated according to the most rigorous scientific and ethical standards.
The OncoPaca-Corse Regional Clinical Trials Register lists all ongoing cancer clinical trials at healthcare facilities in Provence-Alpes-Côte d’Azur, Corsica and the Principality of Monaco.
You can find the list of trials currently underway at the Centre Azuréen de Cancérologie by clicking on the link below:
Why take part in clinical trials?
Clinical trials enable:
The evaluation of treatments that are more targeted, more precise or less toxic,
An improvement in patients’ quality of life,
Access to new treatment options when standard treatment options are limited,
Patients to contribute directly to advances in cancer research.
Who can take part?
Each clinical trial has specific eligibility criteria (type of cancer, stage, previous treatments, etc.).
Inclusion in the clinical research programme is always proposed by the referring doctors after the patient and their family have been provided with clear and comprehensive information.
What are the commitments and safety measures?
The trials are approved by independent scientific and regulatory authorities.
Monitoring is enhanced, with direct access to a dedicated team.
Participation is entirely voluntary: patients may withdraw at any time, without this affecting the quality of their care.
Our aim: to offer tomorrow’s treatments today.